Comparing deep learning and pathologist quantification of cell-level PD-L1 expression in non-small cell lung cancer whole-slide images

Abstract Programmed death-ligand 1 (PD-L1) expression is currently used in the clinic to assess eligibility for immune-checkpoint inhibitors via the tumor proportion score (TPS), but its efficacy is limited by high interobserver variability. Multiple papers have presented systems for the automatic q...

Full description

Bibliographic Details
Main Authors: Leander van Eekelen, Joey Spronck, Monika Looijen-Salamon, Shoko Vos, Enrico Munari, Ilaria Girolami, Albino Eccher, Balazs Acs, Ceren Boyaci, Gabriel Silva de Souza, Muradije Demirel-Andishmand, Luca Dulce Meesters, Daan Zegers, Lieke van der Woude, Willemijn Theelen, Michel van den Heuvel, Katrien Grünberg, Bram van Ginneken, Jeroen van der Laak, Francesco Ciompi
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-57067-1